generalized-anxiety-disorder - Page 1

Treating Anxiety Disorders in Children: The New AACAP Clinical Practice Guideline

March 24, 2022

Reese Abright, MD

Director, Division of Child and Adolescent Psychiatry and Fellowship Training Program in Child and Adolescent Psychiatry, Mount Sinai Services - New York City Health + Hospitals/Elmhurst. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai.

Dr. Abright has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There is a new process for sorting and consolidating treatment recommendations: Clinical Practice Guidelines are the new gold standard. We spoke with Dr. A. Reese Abright about the CPG on anxiety disorders to help you understand where the state of the art is for treating the usual disorders that come up in our clinical practice settings.

Buspirone: Still Effective After All These Years?

February 3, 2021

Eugene Rubin, MD.

Eugene Rubin, MD. Psychiatrist in private practice, Bingham Farms, MI. Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Buspirone (Buspar) is approved for generalized anxiety disorder, but its efficacy there is often questioned. Here we find out how it stacks up against the benzos and SSRIs, and explore its off-label potential in depression, sexual dysfunction, alcoholism, traumatic brain injury, and premenstrual dysphoric disorder.

Rest Easy: Benzos, Z-Drugs, and Dementia

December 31, 2020

James Jenkins, MD.

James Jenkins, MD. Dr. Jenkins has disclosed that he has stock in Alkermes, Sage Therapeutics, Teva Pharmaceutical Industries, Trevena, and Viatris. Dr. Aiken has reviewed this article and has found no evidence of bias pertaining to this educational activity.

It may not be perfect, but this study has the best data yet on the controversial link between benzodiazepines and dementia.

Silexan: A Novel Anxiolytic

July 30, 2020

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This German medication outperformed paroxetine in generalized anxiety disorder and is available over the counter in the U.S.

EXPERT Q&A

Benzodiazepines: Old Medicines, New Concerns

June 10, 2020

Kenneth Morford, MD

Kenneth Morford, MD
Assistant Professor and Program Director, Collaborative Behavioral Health & Addiction Medicine in Primary Care (CHAMP) at Yale School of Medicine. Dr. Morford has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Benzodiazepine use is on the rise, and is implicated with a significant portion of opioid-related overdose deaths. Dr. Morford gives the latest on benzodiazepine prevalence and suggests strategies to employ in addiction treatment settings when working with patients who use benzodiazepines.

Neuroticism and SSRIs

November 18, 2019

Neuroticism is not in the DSM, but it's a common cause of anxiety and may predict thether a patient respond to an SSRI. We talk with Nassir Ghaemi and bring you practical insights into this personality trait. How to recognize it, how to treat it, and how to avoid over-treating...

Pharmacology for GAD: Complex Choices

November 15, 2019

Randall Moore, MD.

Randall Moore, MD. Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A meta-analysis of 25 medications in over 25,000 patients with generalized anxiety disorder. The usual FDA-approved options are there, along with some surprises. Not all are equal, but the most effective of the bunch carries so many side effects that we can only recommend it as a last resort.

A Scandalous History of Anxiety

November 4, 2019

Is Generalized Anxiety Disorder (GAD) an anxious temperament, a symptom of another disorder, or a valid disorder on its own? In Part One of our November series on anxiety, we trace the history of GAD from Sigmund Freud to DSM-5. With over two dozen choices, it isn't easy to pick...

Is Paxil the Best SSRI for Anxiety?

August 30, 2019

Chris Aiken, MD

Chris Aiken, MD Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Paxil built its reputation as the best SSRI for anxiety, but the data suggests the opposite.